Published in Biotech Business Week, April 23rd, 2007
This trend article about Yamaguchi University, Japan, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: New research, "Factors required for the catalytic reaction of PqqC/D which produces pyrroloquinoline quinone," is the subject of a report. According to recent research from Yamaguchi, Japan, "PqqC/D converts the biosynthetic intermediate purified from a pqqC mutant to pyrroloquinoline quinone (PQQ), and both NAD(P)H and cytosolic fraction, named as activating factor (ActF), are required to show its higher production. Dithiothreitol alone, as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.